Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT-ND1 pseudogene 32 (MTND1P32) is a pseudogene, meaning it is a genomic DNA sequence similar to the functional gene MT-ND1 but does not encode a functional protein in the cell[2][6]. As a pseudogene, it lacks biological activity and is not involved in mitochondrial electron transport, oxidative phosphorylation, or disease pathogenesis. Therefore, MTND1P32 is not considered a therapeutic target such as an enzyme, receptor, transporter, or other druggable protein[2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-ND1 pseudogene 32 (MTND1P32).